This award winning investigation investigated why doctors in England’s NHS have been left seemingly unable to prescribe a cheap, safe, and effective drug despite its flourishing use elsewhere. It unearthed conflicts of interest in the NHS and medical charities; a lack of transparency by regulations; and a distortion of European law.

Write A Comment